Kalaris Therapeutics, Inc.

KLRS·NasdaqGM·Healthcare
Compare
2.0200−0.0300 (−1.46%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.0500
Open2.0286
Day range2.01002.1400
52-week range1.780011.8800
Off day high−5.61%
Off 52-week high−83.00%
Volume28.39K
Avg. volume (3M)65.44K
Market cap48.09M
EPS (TTM)-2.02
Forward P/E-1.22
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding23.80M
Short interest3.68% of float
Earnings dateAug 7, 2025 (est.)
Analyst target17.6667
Profit margin0.00%

Against its peers

Compare in full ›
KLRS KALA EYPT TRDA KPRX ALGS
Market cap 48.09M 3.44M 33.12M 197.02M 7.34M 31.35M
P/E (TTM) — — — — — —
Forward P/E -1.2 0.0 -0.2 -1.6 -0.7 -1.0
Price/book 0.8 0.4 0.2 0.8 0.6 1.0
Dividend yield — — — — — —
1-year change −57.29% −99.51% −96.39% −27.19% −28.45% −29.30%
Today −1.46% +2.95% −1.23% +7.20% −4.05% +5.68%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All KLRS news ›

From the 4Search news index, newest first.

In the news

2mentions in 30 days
2with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance